Geode Capital Management’s Emergent Biosolutions EBS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$10.6M Buy
1,272,909
+22,899
+2% +$237K ﹤0.01% 2349
2025
Q4
$15.5M Sell
1,250,010
-28,683
-2% -$307K ﹤0.01% 2147
2025
Q3
$11.3M Sell
1,278,693
-305
-0% -$2.37K ﹤0.01% 2352
2025
Q2
$8.16M Buy
1,278,998
+666,708
+109% +$3.82M ﹤0.01% 2483
2025
Q1
$2.98M Buy
612,290
+21,428
+4% +$177K ﹤0.01% 2889
2024
Q4
$5.65M Buy
590,862
+8,904
+2% +$81.7K ﹤0.01% 2681
2024
Q3
$4.86M Buy
581,958
+25,776
+5% +$234K ﹤0.01% 2771
2024
Q2
$3.79M Sell
556,182
-565,013
-50% -$2.43M ﹤0.01% 2874
2024
Q1
$2.84M Buy
1,121,195
+23,976
+2% +$54K ﹤0.01% 2973
2023
Q4
$2.63M Buy
1,097,219
+78,184
+8% +$184K ﹤0.01% 3005
2023
Q3
$3.47M Buy
1,019,035
+94,551
+10% +$524K ﹤0.01% 2822
2023
Q2
$6.79M Buy
924,484
+28,030
+3% +$260K ﹤0.01% 2529
2023
Q1
$9.29M Buy
896,454
+38,040
+4% +$460K ﹤0.01% 2295
2022
Q4
$10.1M Buy
858,414
+21,994
+3% +$340K ﹤0.01% 2258
2022
Q3
$17.6M Buy
836,420
+4,469
+0.5% +$124K ﹤0.01% 1833
2022
Q2
$25.8M Buy
831,951
+14,304
+2% +$488K ﹤0.01% 1571
2022
Q1
$33.6M Sell
817,647
-25,151
-3% -$1.11M ﹤0.01% 1535
2021
Q4
$36.6M Buy
842,798
+19,726
+2% +$892K ﹤0.01% 1538
2021
Q3
$41.2M Sell
823,072
-19,805
-2% -$1.2M 0.01% 1432
2021
Q2
$53.1M Buy
842,877
+18,945
+2% +$1.22M 0.01% 1254
2021
Q1
$76.6M Buy
823,932
+134,198
+19% +$13.7M 0.01% 919
2020
Q4
$61.8M Buy
689,734
+39,673
+6% +$3.64M 0.01% 965
2020
Q3
$67.2M Sell
650,061
-4,604
-0.7% -$496K 0.01% 770
2020
Q2
$51.8M Buy
654,665
+13,373
+2% +$997K 0.01% 877
2020
Q1
$37.1M Buy
641,292
+39,965
+7% +$2.3M 0.01% 923
2019
Q4
$32.4M Buy
601,327
+23,197
+4% +$1.26M 0.01% 1230
2019
Q3
$30.2M Sell
578,130
-14,243
-2% -$664K 0.01% 1200
2019
Q2
$28.6M Buy
592,373
+48,789
+9% +$2.34M 0.01% 1233
2019
Q1
$27.5M Buy
543,584
+21,768
+4% +$1.28M 0.01% 1204
2018
Q4
$30.9M Buy
521,816
+53,986
+12% +$3.48M 0.01% 991
2018
Q3
$30.8M Buy
467,830
+74,971
+19% +$4.37M 0.01% 1106
2018
Q2
$19.8M Buy
392,859
+56,978
+17% +$2.97M 0.01% 1362
2018
Q1
$17.7M Buy
335,881
+3,954
+1% +$197K 0.01% 1349
2017
Q4
$15.4M Buy
331,927
+2,536
+0.8% +$107K 0.01% 1454
2017
Q3
$13.3M Buy
329,391
+13,932
+4% +$504K ﹤0.01% 1522
2017
Q2
$10.7M Buy
315,459
+1,261
+0.4% +$38.9K ﹤0.01% 1618
2017
Q1
$9.12M Buy
314,198
+25,953
+9% +$790K ﹤0.01% 1677
2016
Q4
$9.46M Buy
288,245
+13,426
+5% +$403K ﹤0.01% 1622
2016
Q3
$8.66M Buy
274,819
+26,428
+11% +$768K ﹤0.01% 1586
2016
Q2
$6.98M Buy
248,391
+31,374
+14% +$1.23M ﹤0.01% 1678
2016
Q1
$7.89K Buy
217,017
+4,680
+2% +$165K ﹤0.01% 1552
2015
Q4
$8.49M Sell
212,337
-9,432
-4% -$329K ﹤0.01% 1492
2015
Q3
$6.32M Buy
221,769
+13,275
+6% +$437K ﹤0.01% 1683
2015
Q2
$6.87M Buy
208,494
+13,982
+7% +$433K ﹤0.01% 1690
2015
Q1
$5.59M Buy
194,512
+9,056
+5% +$260K ﹤0.01% 1797
2014
Q4
$5.05M Buy
185,456
+570
+0.3% +$13.6K ﹤0.01% 1811
2014
Q3
$3.94M Buy
184,886
+18,685
+11% +$428K ﹤0.01% 1913
2014
Q2
$3.73M Sell
166,201
-25,852
-13% -$602K ﹤0.01% 1969
2014
Q1
$4.85M Buy
192,053
+34,786
+22% +$879K ﹤0.01% 1793
2013
Q4
$3.62M Buy
157,267
+11,565
+8% +$241K ﹤0.01% 1937
2013
Q3
$2.78M Buy
145,702
+5,864
+4% +$105K ﹤0.01% 1974
2013
Q2
$2.02M Buy
+139,838
New +$2.02M ﹤0.01% 2028

Other funds holding EBS